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Dear Editor, 
We have read the article by Mittal et al. (1) and we would like to congratulate the authors for an 
excellent piece of work demonstrating spectroscopy’s capability for accurately subtyping 
epithelial cells and the tumor-associated microenvironment. Herein we would like to add some 
insights and comment on how this work could take the field forward. 
In this recent paper, a high-definition Fourier-transform infrared imaging method using a 
quantum cascade laser (QCL) source has been employed for the characterization of 100-case 
breast tissue samples. This advancement has the potential to facilitate label-free molecular 
histopathology and bring spectroscopy one step closer to the clinic: undoubtedly, this study 
would be of great benefit with regards to expediting the diagnostic workflow as well as in terms 
of saving the pathologist’s and / or surgeon’s precious time and caseloads - not to mention 
providing high-quality data. Having said that, the most critical point with regards to patient 
benefit still remains unanswered: 
“Could this technique be used for improving cancer patients’ prognosis and survival?” “Could this 
method allow for an earlier, non-invasive diagnosis while there is still room for timely 
intervention and favorable outcomes (2, 3)?” 
For instance, the technological development of hand-held spectroscopic devices and fiber optics 
has previously shown tremendous promise when it comes to characterization of cancer and could 
be used for in-vivo diagnostics without the need for tissue resection (4-6). Recent studies have 
also shown the promise of biological fluids for a minimally-invasive and pre-symptomatic cancer 
detection (7-9). Different types of machine learning algorithms have been developed to interpret 
spectroscopic data (10) with the aim of detecting cancer. A major field will be the development 
of predictive algorithms in order to identify pre-symptomatic cases that are destined to develop 
the disease; this would allow earlier intervention. 
The results presented in this carefully-conducted work are undeniably a progressive step towards 
an accurate and differential diagnosis; however, we also propose that further spectroscopic / 
clinical research should focus on the development of screening tools for an earlier and minimally 
invasive detection of cancer. 
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